ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0067
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
ProtoKinetix Market Cap
ProtoKinetix has a market cap or net worth of $2.73 million as of March 5, 2026. Its market cap has decreased by -31.08% in one year.
Market Cap
2.73M
Enterprise Value
2.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 7, 2002, ProtoKinetix's market cap has increased from 60.38K to 2.73M, an increase of 4,424.15%. That is a compound annual growth rate of 17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 2.73M | 12.18% |
| Dec 31, 2025 | 2.43M | -34.52% |
| Dec 31, 2024 | 3.72M | -43.47% |
| Dec 29, 2023 | 6.58M | -22.09% |
| Dec 30, 2022 | 8.44M | -71.61% |
| Dec 31, 2021 | 29.74M | 5.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AXIM Biotechnologies | 3.99M |
| Galera Therapeutics | 3.68M |
| Clearside Biomedical | 3.58M |
| Vaccinex | 3.35M |
| Burzynski Research Institute | 3.29M |
| LakeShore Biopharma | 2.47M |
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |